Sensitivity of anti double-stranded RNA used as the universal viral detection in respiratory tract specimens compared with respiratory virus 19 subtypes detection (Microarray)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20180129003

Enrollment

195

Registered

2018-01-29

Start date

2018-04-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with respiratory tract infection who was investigated respiratory virus 19 subtypes (microarray) anti double&#45

Interventions

Patients with respiratory tract infection who was investigated respiratory virus 19 subtypes (microarray)

Diagnostic

Patients with respiratory tract infection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with respiratory tract infection who was admitted in King Chulalongkorn Memorial Hospital, Bangkok, Thailand during April 2018-December 2019 and had investigated for respiratory virus 19 subtypes (microarray)

Exclusion criteria

Exclusion criteria: The respiratory virus 19 subtypes (microarray) result was indetermine

Design outcomes

Primary

Measure	Time frame
Sensitivity of anti double stranded RNA 18 months Immunofluorescence method	—

Secondary

Measure	Time frame
Specificity of anti double stranded RNA 18 months Immunofluorescense method	—

Contacts

Public ContactUdsanee Naoudom

Division of Infectious Diseases, King Chulalongkorn Memorial hospital, Thailand.

airytheair@gmail.com0850754834

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

Sensitivity of anti double&#45;stranded RNA used as the universal viral detection in respiratory tract specimens compared with respiratory virus 19 subtypes detection (Microarray)